Skip to content

aspirin hypersensitivity

comparison of frequency of aspirin hypersensitivity in people with and without nasal polyps

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201408191138N12
Enrollment
96
Registered
2014-09-17
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal polyp. Nasal polyp

Interventions

In both group oral aspirin challenge test is done. On the first day,aspirin with exponentially increasing doses (20,40,80mg),are administered at 3-hour intervals and On the second day,aspirin with e
Diagnosis

Sponsors

Guilan University of Medical Sciences,Vice Chancellor for Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:All patients with nasal polyps that including male and female and in range of 18-60 years old who referred to ENT service in Rasht, Amiralmomenin hospital and diagnosis of nasal polyps is definite for them by endoscopy or CTs if don't have contraindications for oral aspirin challenge test inclusion to our study. Those with contraindications for oral aspirin challenge test were left out of the study : 1-a history of very severe anaphylactic reaction, 2-severe disease of the heart, digestive tract, liver and kidney, 3- infection of respiratory tract within 4weeks prior to the challenges, 4- pregnancy, 5- current treatment with beta receptor blocker. Control group is healthy people that don't have nasal polyps and contraindications for oral aspirin challenge test. Exclusion criteria:If the result of test is positive.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nasoocular symptoms alone. Timepoint: every 1 hour to 3 h after each dose of aspirin. Method of measurement: clinical inspection.;Nasoocular symptoms and a 15% or greater decline in FEV(classic reaction). Timepoint: every 1 hour to 3 h after each dose of aspirin. Method of measurement: clinical inspection and physical exam.;Lower respiratory reaction only (FEV1 declines by >20%). Timepoint: every 1 hour to 3 h after each dose of aspirin. Method of measurement: clinical inspection and physical exam.;Laryngospasm with or without any of the first 3 reactions. Timepoint: every 1 hour to 3 h after each dose of aspirin. Method of measurement: clinical inspection and physical exam.;Systemic reactions: hives, flushing, gastric pain, hypotension. Timepoint: every 1 hour to 3 h after each dose of aspirin. Method of measurement: clinical inspection and physical exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shadman Nemati

Guilan University of Medical Sciences

nemati@gums.ac.ir+98 13 1222 5242

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026